Metraipolis › archive › dc_3083ff51ab04

Assessing efgartigimod dosing patterns and Myasthenia Gravis Activities of Daily Living outcomes in clinical practice: results from a large patient support… — Europe PMC PMID:42598382

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42598382
DOI
10.3389/fneur.2026.1881758
License (as archived)
solo-consultazione
Archived
2026-10-17T07:07:42.316Z
SHA-256 of the archived text
dd5bcb5b388370e392e7f328e6d6edd1f3b81b67fa8cb3af4eef1793ac8c8168
Stable URL of this page
https://metraipolis.com/documento/dc_3083ff51ab04

How to cite

Assessing efgartigimod dosing patterns and Myasthenia Gravis Activities of Daily Living outcomes in clinical practice: results from a large patient support… — Europe PMC PMID:42598382 — Europe PMC (en), https://europepmc.org/article/MED/42598382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3083ff51ab04 (Metraipolis archive dc_3083ff51ab04, sha256 dd5bcb5b388370e392e7f328e6d6edd1f3b81b67fa8cb3af4eef1793ac8c8168)
BibTeX
@misc{dc3083ff51ab04,
  title = {Assessing efgartigimod dosing patterns and Myasthenia Gravis Activities of Daily Living outcomes in clinical practice: results from a large patient support… — Europe PMC PMID:42598382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42598382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3083ff51ab04; sha256 dd5bcb5b388370e392e7f328e6d6edd1f3b81b67fa8cb3af4eef1793ac8c8168},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42598382. Agents can read the archived copy with the MCP tool read_document.